As of October 1, 2022, Bert Seegers is the new CEO of Orikami. Bert has contributed to the growth of Orikami over the past 5 years as Chief Business Officer. Orikami will be pursuing a…
Our mission - to improve 100 million lives before 2030 by enabling personalized healthcare.
We believe health data is underutilized. We use real-world patient data to enable personalized healthcare paths for our clients to improve their quality of life. Therefore, we develop digital biomarkers.
VALUE of Digital Biomarkers
What are digital biomarkers?
Digital biomarkers are defined as objective, quantifiable physiological and behavioral data. They are collected and measured by means of digital devices such as portables, wearables, implantables or digestibles.
Clinical validated digital biomarkers provide objective data that provides clinically significant results. This enables decision support to clinicians and will optimize patients’ health paths.
Measuring participation in MS with the Whereabouts app
Multiple Sclerosis can impact daily life and involvement in societal activities (participation). How do you decide which activities you want to participate in? The MS Center Amsterdam and Orikami have developed the smartphone application ‘Whereabouts’…